SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-005508
Filing Date
2023-08-10
Accepted
2023-08-10 16:01:47
Documents
57
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sonoma_i10q-063023.htm   iXBRL 10-Q 555996
2 CERTIFICATION sonoma_ex3101.htm EX-31.1 8381
3 CERTIFICATION sonoma_ex3102.htm EX-31.2 8272
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4301
  Complete submission text file 0001683168-23-005508.txt   3323265

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20230630.xsd EX-101.SCH 27041
6 XBRL CALCULATION FILE snoa-20230630_cal.xml EX-101.CAL 46524
7 XBRL DEFINITION FILE snoa-20230630_def.xml EX-101.DEF 95041
8 XBRL LABEL FILE snoa-20230630_lab.xml EX-101.LAB 235263
9 XBRL PRESENTATION FILE snoa-20230630_pre.xml EX-101.PRE 194292
51 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-063023_htm.xml XML 363257
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 231159145
SIC: 2834 Pharmaceutical Preparations